文献速递消化系统肿瘤

丹麦2014至2022年基于FIT的结直肠癌筛查性能

Performance of FIT-based colorectal cancer screening in Denmark from 2014 to 2022.
PubMed 文献 · Eur J Cancer · 2026-05-12

丹麦自2014年起逐步实施基于粪便免疫化学试验(FIT)的结直肠癌筛查,2018年起转为两年一次、覆盖50-74岁人群。研究利用全国登记数据评估筛查性能并与欧洲指南比较,结果显示参与率约60%、阳性FIT比例在患病筛查和发病筛查分别为6.9%和4.7%、结肠镜依从性约90%,总体性能在指南可接受范围内但参与率需提高。

要点

  • 丹麦FIT筛查参与率患病筛查61.7%、发病筛查60.5%,需提高。
  • 阳性FIT比例分别为6.9%和4.7%,结肠镜依从性约90%。
  • 筛查后CRC发病率出现峰值后下降,死亡率持续下降。

核心结论

  • 丹麦基于FIT的结直肠癌筛查性能处于欧洲指南可接受水平,但参与率有待提升。

研究设计与样本

  • 基于丹麦全国登记数据的观察性研究,评估2014-2017年患病筛查和2018-2022年发病筛查的性能。

主要发现

  • 患病筛查和发病筛查参与率分别为61.7%和60.5%,阳性FIT比例分别为6.9%和4.7%。
  • 结肠镜随访依从性约90%,腺瘤检出率随时间略有上升,筛查检出CRC数量随时间下降。
  • 结肠镜后3年CRC率在7.1-8.9%间波动,2021年降至6.8%。
  • 筛查引入后CRC发病率出现峰值后下降,死亡率持续下降。

关键数值与推荐

  • 阳性FIT定义为≥20 μg血红蛋白/g粪便,阳性者14天内安排结肠镜。
  • 筛查对象为50-74岁公民,2018年起每两年一次。

临床怎么用

  • 丹麦FIT筛查整体性能达标,但需采取措施提高参与率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Faecal immunochemical test (FIT)-based colorectal cancer (CRC) screening was gradually implemented in Denmark from March 2014 to December 2017. From January 2018, the FIT screening became biennial and is offered to all citizens aged 50-74 years. Citizens with a positive FIT (≥20 μg haemoglobin/g faeces), are scheduled for colonoscopy within 14 days. We examined indicators of quality in FIT-based CRC screening over time and compared with European guidelines. Furthermore, the overall CRC incidence and mortality before, during and after the implementation of CRC screening were examined. METHODS: Nation-wide register data on CRC screening in Denmark were used to assess screening performance during prevalence screening (2014-2017) and incidence screening (2018-2022). For both prevalence and incidence screening we compared results with quality indicators from the European guidelines. Aggregated data on CRC incidence and mortality were obtained from surveillance data. RESULTS: During prevalence and incidence screening, participation in CRC screening was 61.7% and 60.5%, the proportion of positive FITs were 6.9% and 4.7%, respectively. The compliance to follow-up colonoscopy was approximately 90%. The adenoma detection rate increased slightly over time, while number of screen-detected CRC decreased over time. The 3-year post-colonoscopy CRC rate fluctuated around 7.1-8.9% and decreased to 6.8% in 2021. A CRC incidence peak was observed after the introduction of screening followed by a decrease, while mortality continued to decline. CONCLUSION: The performance of FIT-based CRC screening in Denmark is within the acceptable levels defined by the European guidelines; however, improvements are needed, particularly an increase in participation.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Olesen TB, Therkildsen SB, Viborg PH, et al. Performance of FIT-based colorectal cancer screening in Denmark from 2014 to 2022. Eur J Cancer. 2026. PMID: 42142432. doi:10.1016/j.ejca.2026.116788

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。